- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02765451
Study Evaluating Intervention in the Development of Clinical Research in Non-Academic Health Institution (ERNU) (ERNU)
Randomized Trial Evaluating Intervention of the Cancéropôle Nord-Ouest in the Development of Clinical Research in Non-Academic Health Institutions (ERNU)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
French National recommendations ask to increase the accessibility of patients to clinical trials. But this accessibility is far from the optimal care in non-university healthcare institutions (public and private hospital). These non-academic healthcare facilities support at national level about 60% of chemotherapy and 70% of radiotherapy, but only 17% of the inclusions in trials.
A dissociation exist between a care package guaranteed on quality criteria (criteria to obtain the capacity to treat the cancers in healthcare institution) distributed all over the country, and the research, mainly concentrated in few referral centers (University hospital and French Comprehensive Cancer Centers).
Clinical trials allow patients to have early access to new treatments, optimal and formalized information, and supported by physicians in connection with a strict protocol for patients included.
Several studies have shown the existence of geographical and socio-economic determinants for access to reference centers and for the duration of survival of cancer patients. In France, it was found that for patients with gastrointestinal cancer, the remoteness of the place of residence compared to the nearest referral center and a higher level of deprivation decreased the probability of being supported in a reference center.
The hypothesis of the ERNU study is that aid from the Cancéropole Nord-Ouest facilitates clinical research activity resulting in a significant development of inclusions in non-university centers of the french north-west inter-region with an influence on the social and geographical inequalities recruitment.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Abbeville, France, 80142
- Centre Hospitalier d'Abbeville
-
Amiens, France, 80000
- Clinique de l'Europe
-
Amiens, France, 80000
- Clinique Victor PAUCHET
-
Arras, France, 62022
- Centre Hospitalier D'arras
-
Arras, France, 62012
- Hopital Privé d'Arras
-
Avranches, France, 50307
- Centre de Radiothérapie de la Baie
-
Bayeux, France, 14400
- Centre Hospitalier de Bayeux
-
Beauvais, France, 60021
- Centre Hospitalier De Beauvais
-
Beauvais, France, 60000
- Clinique du Parc Saint Lazare
-
Beuvry, France, 62660
- Centre de Radiotherapie Pierre Curie
-
Boulogne sur Mer, France, 62321
- Centre Hospitalier de Boulogne Sur Mer
-
Béthune, France, 62408
- Centre Hospitalier de Béthune
-
Caen, France, 14000
- Centre de Radiothérapie Maurice TUBIANA
-
Caen, France, 14000
- Polyclinique du Parc
-
Calais, France, 62107
- Centre Hospitalier de Calais
-
Cherbourg, France, 52102
- Centre Hospitalier de Cherbourg
-
Compiègne, France, 60200
- Centre Hospitalier Compiègne-Noyon
-
Compiègne, France
- Clinique Saint Côme
-
Coudekerque Branche, France
- Clinique de Flandre
-
Creil, France, 60100
- Centre hospitalier Creil-Senlis
-
Dunkerque, France, 59385
- Centre Hospitalier de Dunkerque
-
Evreux, France, 27015
- Centre Hospitalier intercommunal Eure-Seine
-
Flers, France, 61104
- Centre hospitalier de Flers
-
Granville, France, 50406
- Centre Hospitalier de Granville
-
Hazebrouck, France, 59524
- Centre Hospitalier d'Hazebrouck
-
Helfaut, France, 62505
- Centre hospitalier de Saint Omer
-
Laon, France, 02001
- Centre Hospitalier de Laon
-
Le Havre, France, 76083
- Centre Hospitalier du Havre
-
Lens, France, 62307
- Centre Hospitalier de LENS
-
Lille, France, 59000
- Centre de radiuothérapie Bourgogne
-
Rang du Fliers, France, 62180
- Centre Hospitalier d'arrondissement de Montreuil sur mer
-
Rouen, France, 76175
- Clinique Mathilde
-
Saint Aubin sur Scie, France, 76550
- Clinique les Aubépines
-
Saint Martin des Champs, France, 50300
- Clinique de la Baie
-
Saint Quentin, France, 02321
- Centre Hospitalier de Saint Quentin
-
Saint Quentin, France, 02100
- Clinique Saint Claude
-
Saint-Omer, France, 62575
- Clinique de Saint-Omer
-
Soissons, France, 02209
- Centre Hospitalier de Soissons
-
Tourcoing, France, 59208
- Centre Hospitalier de Tourcoing
-
Valenciennes, France, 59300
- Centre Hospitalier de Valenciennes
-
saint Aubin lès Elbeuf, France, 76503
- Centre Hospitalier intercommunal d'Elbeuf-Louvier
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- French Health institutions of the Basse-Normandie, Haute-Normandie, Nord-Pas-de-Calais and Picardie.
- Health institutions non-academic public and private.
- Health institutions authorized to treat cancer.
Exclusion Criteria:
- N/A
Study Plan
How is the study designed?
Design Details
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: A : 1 year of intervention
interventions of Cancéropôle Nord-Ouest during 1 year after an observational period of 2 years.
|
During the time defined by the randomization, the Cancéropôle Nord-Ouest offers to help to develop a clinical research activities in the centers.
The various aids are : Structuring clinical research at the local level, Support (strategy, logistics, technical, Data management, methodology), a portfolio of "straightforward" studies ( French National Cancer Institute, cooperative groups conducting cancer clinical research, New Project), Good Clinical Practice training, Clinical research technician, Others,.....
|
ACTIVE_COMPARATOR: B : 2 years of intervention
interventions of Cancéropôle Nord-Ouest during 2 years after an observational period of 1 year.
|
During the time defined by the randomization, the Cancéropôle Nord-Ouest offers to help to develop a clinical research activities in the centers.
The various aids are : Structuring clinical research at the local level, Support (strategy, logistics, technical, Data management, methodology), a portfolio of "straightforward" studies ( French National Cancer Institute, cooperative groups conducting cancer clinical research, New Project), Good Clinical Practice training, Clinical research technician, Others,.....
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of inclusions in clinical trials of patients
Time Frame: up to 2 years
|
Measure the increase in inclusions in clinical trials of patients attending a Hospital or a private clinic "authorized to treat cancer" associated with a support provided by the Cancéropôle Nord-Ouest
|
up to 2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Reduction of social inequalities recruitment in clinical trials associated with the intervention of the Cancéropôle Nord-Ouest
Time Frame: up to 2 years
|
assessment of the average of the reduction of social inequalities recruitment in clinical trial before and after the intervention of the Cancéropöle Nord-Ouest in each centers and in global.
the social inequalities are calculated with the social and demographic tool developped by the french national institute of statistic and economic studies
|
up to 2 years
|
Collaborators and Investigators
Collaborators
Investigators
- Study Director: Jean-Claude BARBARE, MD, Centre Hospitalier Universitaire Amiens-Picardie
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- RNI 2015-05-DR-BARBARE
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
University of Michigan Rogel Cancer CenterRecruitingCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
Vanderbilt-Ingram Cancer CenterNational Institutes of Health (NIH)Active, not recruitingAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterHyundai Hope On WheelsRecruitingCancer | Pediatric Cancer | Survivorship | Cancer MetastaticUnited States
-
MiRXES Pte LtdRecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Thoracic Cancer | Liver CancerSingapore
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedStage I Breast Cancer | Stage I Uterine Corpus Cancer | Stage II Uterine Corpus Cancer | Stage III Uterine Corpus Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage... and other conditionsUnited States
-
Massachusetts General HospitalNational Comprehensive Cancer NetworkCompletedGastric Cancer | Pancreatic Cancer | Esophageal Cancer | Rectal Cancer | Colon Cancer | Hepatobiliary CancerUnited States
-
Johns Hopkins UniversityNational Cancer Institute (NCI); National Institute on Minority Health and...Enrolling by invitationCancer | Advanced Cancer | End Stage Cancer | MalignancyUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
University of California, San FranciscoBristol-Myers Squibb; PfizerTerminatedStage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Metastatic Colorectal Adenocarcinoma | Metastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Stage IV Colon Cancer | Stage IV Rectal... and other conditionsUnited States
Clinical Trials on interventions of the Cancéropôle Nord-Ouest
-
Hospices Civils de LyonRecruiting
-
Thomas Jefferson UniversityCompleted
-
Tulane UniversityNational Institutes of Health (NIH)RecruitingChurch-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health (CHERISH)Cardiovascular Diseases | Hypertension | Diabetes | HypercholesterolemiaUnited States
-
Yasemin OzhunerActive, not recruiting
-
University of AberdeenRecruitingLichen Planus, Oral | Lichen Planus of VulvaUnited Kingdom
-
King's College LondonUniversity College Hospital, Ibadan; Lagos State University; Obafemi Awolowo... and other collaboratorsCompletedInguinal Hernia | Appendicitis | Gastroschisis | Intussusception | Anorectal MalformationUnited Kingdom
-
Radboud University Medical CenterAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)UnknownRectal Cancer | Anastomotic Leak Rectum
-
National Taiwan University HospitalCompletedLung Diseases | Tracheal Diseases | Total Intravenous AnesthesiaTaiwan
-
Chinese University of Hong KongThe Queen Elizabeth HospitalUnknown
-
T.C. ORDU ÜNİVERSİTESİCompletedThe Effect of Supportive Nursing Interventions of Mothers of Infants in Neonatal Intensive Care UnitStress, PsychologicalTurkey